AKT1 and colorectal carcinoma: Combined treatment with CBIs and fasting blunted AKT phosphorylation in Capan-1 and HCT116 tumour xenografts, as well as in CRC tumour organoids (Fig. 6a and Supplementary Fig. 6a–c).